Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ELANE | P08246 | 16/20 | 0.76 |
| ▸ | RAB9A | P51151 | 1/20 | 0.50 |
| ▸ | PRTN3 | P24158 | 2/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10483720 | 0.86 | ELANE (1.00) | ELANEPRTN3 | |
| SCHEMBL22369614 | 0.85 | ELANE (0.86) | ELANEPRTN3 | |
| SCHEMBL12737001 | 0.85 | ELANE (0.56) | ELANERAB9AALDH1A1 | |
| SCHEMBL3657615 | 0.85 | ELANE (0.76) | ELANEPRTN3 | |
| SCHEMBL3657617 | 0.85 | ELANE (0.76) | ELANEPRTN3 | |
| SCHEMBL10457684 | 0.84 | ELANE (0.60) | ELANE | |
| SCHEMBL9299504 | 0.83 | ELANE (0.73) | ELANEPRTN3 | |
| SCHEMBL7276499 | 0.83 | ELANE (0.73) | ELANEPRTN3 | |
| SCHEMBL14870980 | 0.83 | ELANE (0.73) | ELANEPRTN3 | |
| SCHEMBL10973406 | 0.83 | ELANE (0.73) | ELANEPRTN3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20160355516-A1 | NITROGEN CONTAINING COMPOUNDS AND THEIR USE AS ANTIBACTERIAL AGENTS | WOCKHARDT LIMITED (IN) | 2016-12-08 | — | — | US | disclosed |
| US-9164392-B2 | Developer and patterning process | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2015-10-20 | — | — | US | disclosed |
| WO-2015110969-A2 | NITROGEN CONTAINING COMPOUNDS AND THEIR USE | WOCKHARDT LIMITED (IN) | 2015-07-30 | — | — | WO | disclosed |
| US-20140315131-A1 | DEVELOPER AND PATTERNING PROCESS | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2014-10-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160355516-A1 | NITROGEN CONTAINING COMPOUNDS AND THEIR USE AS ANTIBACTERIAL AGENTS | NOS2, NOS1, NCF1 | ELANE 6/4885RAB9A 2610/4885PRTN3 400/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.